Massive Hemoptysis in Children

Juan Yang1,2, Fengqin Liu1,2, Yan Liang1,2

  • 1Department of Pediatric, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, China.

Insights

Massive hemoptysis in children, though rare, is life-threatening. This case highlights bronchial artery malformation as an unusual cause, successfully treated with bronchial artery embolization and bronchoscopy.

Area of Science:

  • Pediatric Pulmonology
  • Interventional Radiology
  • Vascular Malformations

Background:

  • Massive hemoptysis is a critical pediatric emergency with significant mortality risk.
  • Common etiologies include lower respiratory tract infections, vascular malformations, and foreign bodies.
  • Bronchial artery malformations represent a rare but severe cause of hemoptysis.

Observation:

  • An 11-year-old boy presented with mild hemoptysis, progressing to massive bleeding.
  • Initial chest X-ray suggested pneumonia; however, massive hemoptysis indicated a more complex underlying issue.
  • Diagnostic bronchial arteriography identified hypertrophied bronchial artery and an ectopic bronchial artery from the renal artery as the sources.

Findings:

  • Bronchial artery embolization (BAE) successfully occluded the aberrant vessels.
  • Bronchoscopy facilitated removal of airway blood clots, improving respiratory status.
  • The patient experienced complete recovery without complications following the interventions.

Implications:

  • Bronchial artery malformations require prompt diagnosis and multidisciplinary management.
  • Advanced imaging like CT angiography and arteriography are crucial for identifying vascular sources.
  • Timely embolization and airway clearance are vital for managing life-threatening pediatric hemoptysis.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
165
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
726
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
388
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
733